GOG Foundation
J

Maintenance Therapy Clinical Trials in Newly Diagnosed Ovarian Cancer Are Positive for Prolonged PFS With BRCA Deriving the Most PFS Benefit

By GOG Foundation FEATURING Joyce Liu
By GOG Foundation FEATURING Joyce Liu
406 views
January 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn

Related Content

AUTOPLAY
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:50
Fengting Yan

Year in Review: Ovarian Cancer

25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux
08:37
Fred Hutchinson Cancer Center

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Feat. K. Banda
24:12
Jubilee Brown

Rare Ovarian Cancer: Epithelial Tumors

08:19
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT…

Feat. M. Raza Mirza
13:58
ISCO - International School of Clinical Oncology

Novel Therapies and Combinations in Ovarian Cancer

Feat. A. Leary
28:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

The Role of Immunotherapy and Targeted Therapy in GYN Cancers

Feat. S. Gaillard
18:57
ESMO 2022 Conference Coverage

ESMO 2022: Should All Advanced Ovarian Cancer Patients Receive a PAR…

Feat. D. Tan
11:32
SGO 2023 Conference Coverage on VuMedi

SGO 2023 GOG 3026 Phase II Trial of Letrozole + Ribociclib in Women …

Feat. B. Slomovitz
13:04
Nebraska Oncology Society

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Feat. M. Clark
23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin
17:06
2023 Evolution Conference

Genetic Testing in Early and Recurrent Ovarian Cancer

Feat. J. Barr